- Trump administration sues Gilead
The Trump administration filed a lawsuit against Gilead Nov. 6, accusing the drugmaker of making billions of dollars from taxpayer-funded research without paying taxpayers back. - Sanofi to pay $315M to settle claims it purposefully slowed MS drug development
Sanofi has agreed to pay $315 million to settle claims that it slowed the development of a multiple sclerosis drug to avoid paying investors after the company acquired Genzyme Corp. - 15 drugmakers to pay $242M to settle Illinois Medicaid fraud suit
Fifteen drugmakers will pay the state of Illinois $242 million to settle allegations they published inflated average wholesale price information to increase Medicaid reimbursements, Illinois Attorney General Kwame Raoul said Oct. 28. - Patient charities pay $6M to settle Medicare kickback allegations
The Chronic Disease Foundation and the Patient Access Network Foundation paid $6 million to settle claims they helped drugmakers pay kickbacks to Medicare patients. - Massachusetts biotech sues CMS for denying coverage of its drug
Akebia Therapeutics, a small Cambridge, Mass.-based drugmaker, has filed a lawsuit against CMS, claiming Medicare’s denial to cover its anemia drug violates the law. - Sanofi, other drugmakers accused of intentionally hiding carcinogen in Zantac
Consumers have sued several Zantac manufacturers for allegedly failing to disclose that the heartburn drug can produce small amounts of a possible carcinogen. - Ex-CSL exec stole trade secrets before joining rival, lawsuit claims
A new lawsuit claims a former CSL Behring senior medical affairs director stole more than 21,000 files containing valuable trade secrets before he left the company for a job at Pharming, a competing drugmaker. - J&J to pay $117M to settle pelvic mesh suits
Johnson & Johnson and its subsidiary Ethicon will pay nearly $117 million to settle claims that they misrepresented the risks of transvaginal surgical mesh devices. - Pharmacist sues New York hospital, says she was fired after reporting misconduct
A former clinical pharmacist at Strong Memorial Hospital has filed a lawsuit claiming the Rochester, N.Y.-based provider fired her after she reported patient safety concerns and harassment. - Jury orders J&J to pay $8B in Risperdal case
A Philadelphia jury ordered Johnson & Johnson to pay $8 billion in punitive damages in a case accusing the drugmaker of downplaying the risks associated with its antipsychotic drug, Risperdal. - J&J, 2 Ohio counties reach $20M opioid settlement
Johnson & Johnson has agreed to pay $20.4 million to avoid the first federal trial that accuses the drugmaker of fueling the opioid epidemic. - Avanir Pharmaceuticals to pay $116M to settle bribery charges
Avanir Pharmaceuticals agreed to pay $116 million to settle a lawsuit alleging it illegally marketed its drug Nuedexta. - Mylan agrees to pay $30M to settle lawsuit over EpiPen pricing
Mylan agreed to pay $30 million to settle a lawsuit claiming it failed to disclose to investors a 2017 U.S. Justice Department probe into whether it overcharged Medicaid for its EpiPen allergy treatment. - Walgreens to settle class-action suit over ad restrictions
Walgreens agreed Sept. 17 to settle a class-action lawsuit alleging it violated antitrust laws by restricting search advertisements. - CVS to pay $4.4M settlement over inadvertent HIV disclosure of 4,500 patients
CVS Health agreed to pay $4.4 million to settle a lawsuit accusing it of exposing the HIV status of roughly 4,500 Ohio patients. - Purdue Pharma reaches tentative deal to settle opioid suits
OxyContin maker Purdue Pharma has reached a tentative deal with 23 states and more than 2,000 cities and counties that sued the company over its role in the opioid crisis.
More articles on pharmacy:
Amgen exits neuroscience research, cuts 180 US jobs
Walgreens’ exit from health clinic business should serve as a warning to rivals
Top 10 pharmacy stories in October
